HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreia Luiza Pereira Silva Selected Research

LQFM-091

8/2017Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreia Luiza Pereira Silva Research Topics

Disease

1Edema (Dropsy)
08/2017
1Hyperalgesia
08/2017
1Inflammation (Inflammations)
08/2017

Drug/Important Bio-Agent (IBA)

1LQFM-091IBA
08/2017
1Analgesics (Analgesic Drugs)IBA
08/2017
1CarrageenanIBA
08/2017
1Formaldehyde (Formol)FDA Link
08/2017
1Peroxidase (Myeloperoxidase)IBA
08/2017
1CytokinesIBA
08/2017